Related Experiment Video
Updated: Oct 29, 2025

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
Published on: November 26, 2015
Mechanisms Involved in Ototoxicity
1Oregon Hearing Research Center, Oregon Health and Science University, Portland, Oregon.
Abstract:
The modern era of evidence-based ototoxicity emerged in the 1940s following the discovery of aminoglycosides and their ototoxic side effects. New classes of ototoxins have been identified in subsequent decades, notably loop diuretics, antineoplastic drugs, and metal chelators. Ototoxic drugs are frequently nephrotoxic, as both organs regulate fluid and ion composition. The mechanisms of ototoxicity are as diverse as the pharmacological properties of each ototoxin, though the generation of toxic levels of reactive oxygen species appears to be a common denominator. As mechanisms of cytotoxicity for each ototoxin continue to be elucidated, a new frontier in ototoxicity is emerging: How do ototoxins cross the blood-labyrinth barrier that tightly regulates the composition of the inner ear fluids? Increased knowledge of the mechanisms by which systemic ototoxins are trafficked across the blood-labyrinth barrier into the inner ear is critical to developing new pharmacotherapeutic agents that target the blood-labyrinth barrier to prevent trafficking of ototoxic drugs and their cytotoxic sequelae.
Insights
Ototoxicity, or drug-induced hearing loss, is a growing concern. Understanding how ototoxic drugs cross the blood-labyrinth barrier is key to developing protective therapies.
Area of Science:
- Ototoxicity research
- Pharmacology
- Neuroscience
Background:
- Evidence-based ototoxicity research began in the 1940s with aminoglycosides.
- Subsequent decades identified loop diuretics, antineoplastic drugs, and metal chelators as ototoxic agents.
- Ototoxic drugs often exhibit nephrotoxicity due to shared organ functions.
Purpose of the Study:
- To explore the emerging frontier of ototoxin trafficking across the blood-labyrinth barrier.
- To understand the mechanisms by which systemic ototoxins enter the inner ear.
- To inform the development of novel pharmacotherapeutic strategies for preventing drug-induced hearing loss.
Main Methods:
- Review of ototoxicity literature.
- Analysis of drug mechanisms and physiological barriers.
- Identification of common cytotoxic pathways, such as reactive oxygen species generation.
Main Results:
- Reactive oxygen species generation is a common mechanism in ototoxicity.
- The blood-labyrinth barrier presents a significant challenge to inner ear drug entry.
- Mechanisms of ototoxin transport across this barrier remain largely unknown.
Conclusions:
- Elucidating ototoxin transport across the blood-labyrinth barrier is critical.
- Targeting this barrier offers a new therapeutic avenue for preventing ototoxicity.
- Further research is needed to develop targeted pharmacotherapies to protect hearing.
Related Concept Videos
Auditory Pathway
When viewed cross-sectionally, the cochlea reveals the scala vestibuli and scala tympani flanking...
The Cochlea
Hair Cells
Mechanically-gated Ion Channels
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Anatomy of the Ear

